this post was submitted on 22 Nov 2023
83 points (93.7% liked)

Health - Resources and discussion for everything health-related

2348 readers
245 users here now

Health: physical and mental, individual and public.

Discussions, issues, resources, news, everything.

See the pinned post for a long list of other communities dedicated to health or specific diagnoses. The list is continuously updated.

Nothing here shall be taken as medical or any other kind of professional advice.

Commercial advertising is considered spam and not allowed. If you're not sure, contact mods to ask beforehand.

Linked videos without original description context by OP to initiate healthy, constructive discussions will be removed.

Regular rules of lemmy.world apply. Be civil.

founded 1 year ago
MODERATORS
 

Millions of older adults likely have minor memory issues that can later become dementia. But only a fraction of them are diagnosed early enough for new treatments to stand a chance.

Millions of people over the age of 65 likely have mild cognitive impairment, or MCI—minor problems with memory or decisionmaking that can, over time, turn into dementia. But a pair of recent studies both concluded that 92 percent of people experiencing MCI in the United States are not getting diagnosed at an early stage, preventing them from accessing new Alzheimer’s treatments that may be able to slow cognitive decline if it’s caught soon enough.

“We knew it was bad. But we didn’t know it was that bad,” says Ying Liu, a statistician at the University of Southern California Dornsife's Center for Economic and Social Research and a researcher on both studies.

you are viewing a single comment's thread
view the rest of the comments
[–] Chetzemoka@startrek.website 1 points 1 year ago (1 children)

Who said anything about replacing clinical MCI exams with invasive scans? (I'm terrible; I didn't read the article. I wouldn't agree with replacing exams with invasive scans.) We just need better MCI exams. The ones we have now are flawed. They are not catching people who are clearly already symptomatic, and who therefore should be started on one of the existing options for small molecule drugs.

Also all of our current research uses the existing MCI exams for assessment and often endpoint, which deeply complicates things if the exams don't even catch what they were intended to catch.

[–] Ranvier@sopuli.xyz 1 points 1 year ago

These are the requirements to use the new anti amyloid drugs (the ones that purportedly do change disease progression, unlike current small molecule drugs), which need amyloid pet imaging plus regular mris to monitor for complications. Sorry if I was unclear.